Purpose. Previous research demonstrated that IL-10 was up-regulated in Chlamydia trachomatis-infected cells and that exogenous IL-10 was able to inhibit the secretion of pro-inflammatory cytokines by infected cells. However, the mechanisms are not well understood. The aim of this study was to investigate the mechanisms for up-regulation of IL-10 and inhibition of pro-inflammatory cytokine secretion in C. trachomatis-stimulated peripheral blood mononuclear cells (PBMCs).
INTRODUCTION
Chlamydia is an obligate intracellular bacterium with an innate biphasic life cycle [1, 2] . The infection starts with the uptake of infectious elementary bodies (EBs) by eukaryotic cells, and then EBs differentiate to metabolically active reticular bodies (RBs) which replicate in a binary fission manner in an intracellular vacuole (inclusion). The progeny RBs further differentiate to EBs. At the end of the infectious cycle, EBs are released from the host cells and then infect new target cells [3] . Chlamydial infections, which are typically asymptomatic and in which reinfections are common, are the cause of a number of human diseases. For example, Chlamydia trachomatis is the leading cause of preventable blindness in most developing countries [4] and is also the most common sexually transmitted infection, causing pelvic inflammatory diseases, infertility and ectopic pregnancy [5] . Chlamydia pneumoniae is a common cause of respiratory tract diseases and has been implicated in coronary artery diseases [6, 7] .
Immune responses to pathogens involve the rapid activation of pro-inflammatory cytokines, such as IL-6, IL-8 and TNF-a, which serve to initiate the host defences against microbial invasion. Production of pro-inflammatory cytokines is required for the clearance of pathogens. However, excessive production contributes to disease manifestation by damaging neighbouring cells [8, 9] . Some intracellular pathogens can regulate host cell immune responses via up-regulation of anti-inflammatory cytokines, such as IL-10, leading to persistent infection [10] [11] [12] [13] . IL-10 is secreted by a variety of cell types, including T cells, B cells, monocytes, macrophages and dendritic cells [14, 15] . However, CD14+ monocytes are the main source of IL-10 in C. trachomatis-infected PBMCs compared to uninfected cells [16] . It has been demonstrated that IL-10 plays important roles in the regulation of immune responses against infectious agents by suppressing the secretion of pro-inflammatory cytokines, thereby impairing the clearance of pathogens [17] . IL-10 immunosuppressive activity is mediated via a heterodimeric IL-10 receptor. The binding of IL-10 to IL-10R results in phosphorylation of protein kinase JAK and TYK2, and then JAKs phosphorylate the signal transducer and activator of transcription 3 (STAT3) tyrosine residues. Phosphorylated STAT3 homodimerizes and translocates into the nucleus, interacting with SBE regions within the promoters of IL-10 target genes, which leads to major changes in the expression profile of immunomodulatory genes [18] .
Previous research demonstrated that certain intracellular pathogens can induce the secretion of IL-10 by activating host cell signalling pathways in order to establish persistent infection [10] [11] [12] [13] . Chlamydia relies on the host cells to survive and propagate and can persist in those cells for long periods of time, which is probably due to the weak immune responses. IL-10 has previously been demonstrated to be significantly up-regulated in Chlamydia-infected PBMCs [16, 19, 20] . However, the mechanisms involved in up-regulation of IL-10 in human PBMCs during Chlamydia infection are poorly understood. Yilma et al. reported that exogenous IL-10 is able to inhibit the secretion of IL-6, IL-8 and TNF-a by C. trachomatis-infected human epithelial cells and mouse macrophages [21] . However, the molecular mechanisms are not well understood. In addition, it is unclear whether endogenous IL-10 has the same function in C. trachomatis-stimulated human PBMCs.
In this study, we explored the hypothesis that endogenous IL-10, which is induced via host cell signalling pathways, may inhibit the production of pro-inflammatory cytokines by activating the JAK/STAT pathway in C. trachomatisstimulated human PBMCs. To address this hypothesis, we used human PBMCs as target cells and C. trachomatis as the stimulant. We first verified that IL-10 was upregulated in C. trachomatis-stimulated human PBMCs, while chemical inhibitors of ERK and p38 reduced the production of IL-10. Then we further demonstrated that endogenous IL-10 reduced the expression of proinflammatory cytokines IL-6, IL-8 and TNF-a and induced STAT3 phosphorylation. Inhibition of STAT3 phosphorylation increased the production of IL-6, IL-8 and TNF-a in stimulated cells. These results indicate that endogenous IL-10, which is induced in an ERK-and p38-dependent fashion in C. trachomatis-stimulated human PBMCs, inhibits the production of pro-inflammatory cytokines by activating the JAK/STAT pathway.
METHODS
Propagation of Chlamydia C. trachomatis serovar L2 was propagated in HeLa 229 cells and purified as described previously [22] . Briefly, HeLa 229 cells infected with C. trachomatis for 48 h were harvested with a rubber policeman and suspended with SPG (219 mM sucrose, 12 mM phosphate buffer, 5 mM glutamic acid, pH 7.2), and then the cells were briefly sonicated to release the chlamydial elementary bodies (EBs). After centrifugation at 1000 g at 4 C for 10 min, the supernatants containing EBs were removed and EBs were purified using discontinuous Renografin gradients. Purified EBs were aliquoted and stored at À80 C until use. The infectivity of Chlamydia EBs was titrated by determination of inclusionforming units (IFU) as described previously [20] .
Human PBMC preparations and Chlamydia stimulation Peripheral blood mononuclear cells (PBMCs) were isolated from the blood of healthy human donors who had not previously been exposed to C. trachomatis, by standard Ficoll-Hypaque (Pharmacia) density gradient centrifugation. Cells were washed three times with PBS and suspended in RPMI-1640 medium (Invitrogen) containing 10 % heatinactivated fetal calf serum. 5Â10 4 PBMCs/well in a 96-well plate were stimulated with C. trachomatis at a multiplicity of infection (MOI) of 3, or as indicated in individual experiments, and then cultured at 37 C in a humidified incubator supplied with 5 % CO 2 in RPMI 1640 medium. In some experiments, cells were stimulated with C. trachomatis in the presence or absence of various chemical inhibitors or anti-human IL-10 antibody before their exposure to the inoculum.
Real-time PCR
Total RNA was extracted using a Total RNA Kit (Beyotime Institute of Biotechnology, Jiangsu, China). The RNA was transcribed using a Reverse Transcription Kit (Beyotime Institute of Biotechnology, Jiangsu, China) to obtain cDNA. RT-PCR primers were as follows: for IL-10 transcripts, (forward) 5¢-ATGCCCCAAGCTGAGAACCAAGACCCA-3¢ and (reverse) 5¢-TCTCAAGGGGCTGGGTCAGCTA TCCCA-3¢; for IL-8 transcripts, (forward) 5¢-ATGAC TTCCAAGCTGGCCGTGGCT-3¢ and (reverse) 5¢-TC TCAGCCCTCTTCAAAAACTTCTC-3¢; for IL-6 transcripts, (forward) 5¢-AGGAGACTTGCCTGGTGAAA-3¢ and (reverse) 5¢-CAGGGGTGGTTATTGCATCT-3¢; for TNF-a transcripts, (forward) 5¢-TCAGAGGGCCTGTACC TCAT-3¢ and (reverse) 5¢-GGAAGACCCCTCCCAGA TAG-3¢; for b-actin transcripts, (forward) 5¢-CTACAA TGAGCTGCGTGTGG-3¢ and (reverse) 5¢-TAGCTCTTC TCCAGGGAGGA-3¢. Amplification was carried out as described previously [23] . mRNA copy numbers were normalized by comparison to housekeeping b-actin copy numbers expressed relative to mock control.
Measurement of cytokine production from cell culture supernatants Cytokines were measured from stimulated or unstimulated culture supernatants using enzyme-linked immunosorbent assay kits (Boster, Wuhan, China) according to the manufacturer's instructions.
IL-10 neutralization
To prevent the effects of IL-10 in selected experiments, IL-10 antibody blocking was performed as described previously [23] . The PBMC cultures were treated with 10 µg ml À1 antihuman IL-10 antibody (R&D) for 2 h. These treated cells were then stimulated with C. trachomatis. After 48 h, culture supernatants and cells were collected.
Western blot assay
Western blot assay was carried out as described previously [22] . Briefly, cell culture samples were lysed with lysis buffer in the presence of protease inhibitor cocktail (Amresco), and the lysates were subjected to SDS-polyacrylamide gel separation. After the proteins were blotted onto nitrocellulose membranes, primary antibodies were applied. These included mouse monoclonal antibodies to anti-p44/42 MAPK (ERK1/2) (no.4696), anti-phospho-p44/42 MAPK (p-ERK1/2) (no.5726), anti-p38 MAPK (no.9228), antiphospho-p38 MAPK (no.9216), anti-STAT3 (no.9139) and anti-phospho-STAT3 (no.4113) (Cell Signaling Technology). The primary antibody binding was probed with corresponding secondary antibodies conjugated with horseradish peroxidase, and proteins were visualized with an enhanced chemiluminescence kit (Pierce).
Statistical analysis
The statistical software SPSS version 16.0 was used for data analyses. All data were expressed as mean±standard deviaations (SD). An un-paired, two-tailed Student's t test was performed to determine the statistical significance of the data, and P values <0.05 were considered significant.
RESULTS
C. trachomatis up-regulates the expression of IL-10 at both mRNA and protein levels in human PBMCs Geng Y et al. reported that IL-10 is up-regulated in Chlamydia pneumoniae-stimulated human PBMCs [20] . To determine whether C. trachomatis could induce the production of IL-10 in human PBMCs, we tested for the protein levels of IL-10 in C. trachomatis-stimulated human PBMCs. As shown in Fig. 1(a) , IL-10 concentrations in the culture supernatants of human PBMCs cultured with C. trachomatis were increased significantly. We further investigated the mRNA levels of IL-10. As shown in Fig. 1(b) , IL-10 mRNA levels were also enhanced significantly by C. trachomatis. In addition, the correlation between the level of C. trachomatis and IL-10 production or IL-10 mRNA expression was dosedependent. Furthermore, our studies showed that in comparison with unstimulated cells at different time points after C. trachomatis stimulation, the production of IL-10 from C. trachomatis-stimulated human PBMCs began to increase at 8 h post-stimulation, and peaked at 48 h (Fig. 1c) .
Inhibition of MAPK/ERK and MAPK/P38 pathways reduces the production of IL-10 As IL-10 has been shown to be profoundly regulated by the ERK and P38 pathways in innate immune cells [24, 25] , we investigated the role of these two pathways in the upregulation of IL-10 in stimulated human PBMCs. To perform these experiments, we first checked whether the two pathways were activated in stimulated cells. Previous studies have demonstrated that chlamydial infection can activate the two signalling pathways in infected cells [26, 27] . As expected (Fig. 2a) , chlamydial stimulation not only activated the ERK signalling pathway, but also the P38 signalling pathway. Phosphorylated ERK was up-regulated at 8 h post-stimulation and in a time-dependent manner. Phosphorylated P38 was up-regulated at 12 h post-stimulation and also in a timedependent manner. To further investigate whether the ERK and P38 pathways would play any role in modulating IL-10 levels in stimulated cells, we exploited the use of chemical inhibitors. Human PBMCs were stimulated in the presence or absence of MEK-1 inhibitor U0126 or the P38 inhibitor, SB203580. As shown in Fig. 2(b) , IL-10 mRNA expression in stimulated cells was significantly decreased and in a dosedependent manner when treated with either U0126 or SB203580. Similar results were obtained at the protein level in stimulated cells treated with inhibitors (Fig. 2c) .
Neutralization of IL-10 released by human PBMCs enhances the levels of C. trachomatis-induced IL-6, IL-8 and TNF-a expression In the current study, we have shown that C. trachomatis can induce human PBMCs to secrete IL-10. Because exogenous IL-10 can reduce the production of IL-6, IL-8 and TNF-a in C. trachomatis-infected epithelial cells and macrophages [21] , we wanted to determine whether endogenous IL-10 has the same function as exogenous IL-10 in C. trachomatis-stimulated human PBMCs. An anti-human IL-10 antibody was utilized to treat human PBMCs. As shown in Fig. 3(a) , although C. trachomatis can induce human PBMCs to secrete IL-6, IL-8 and TNF-a, neutralization of IL-10 using anti-IL-10 antibody resulted in a significant increase in culture supernatant IL-6, IL-8 and TNF-a protein levels. We further tested the mRNA levels of IL-6, IL-8 and TNF-a in C. trachomatis-stimulated cells by real-time PCR assay. As shown in Fig. 3(b) , the levels of IL-6, IL-8 and TNF-a mRNA were also enhanced significantly when PBMCs were treated with anti-IL-10 antibody.
C. trachomatis-induced STAT3 phosphorylation is dependent on IL-10 Two series of experiments were done in order to examine whether endogenous IL-10 induced by C. trachomatis would promote STAT3 phosphorylation. In the first series, we sought to establish whether C. trachomatis stimulation would induce STAT3 phosphorylation in human PBMCs. As shown in Fig. 4(a) , human PBMCs stimulated with C. trachomatis for 8 h displayed a minimal level of phosphorylated STAT3, and these levels continued to increase as the stimulation progressed. In addition, we found that the phosphorylated STAT3 correlated well with chlamydial stimulation dose, and as the stimulation doses increased, higher levels of phosphorylated STAT3 were detected (Fig. 4b) . In the second series, we sought to establish whether STAT3 phosphorylation is dependent on IL-10. An IL-10 antibody was utilized to treat human PBMCs. As shown in Fig. 4(c) , neutralization of IL-10 using anti-IL-10 antibody resulted in a significant decrease in phosphorylated STAT3, suggesting the potential role of IL-10 production in C. trachomatis-induced STAT3 phosphorylation.
Inhibition of STAT3 phosphorylation increases the production of IL-6, IL-8 and TNF-a in stimulated cells
We next used the inhibitor Ruxolitinib, which is a selective JAK inhibitor, to test whether inhibition of phosphorylated STAT3 expression promotes the production of IL-6, IL-8 and TNF-a in stimulated human PBMCs. First, we examined whether Ruxolitinib could inhibit STAT3 phosphorylation in C. trachomatis-stimulated human PBMCs. As expected (Fig. 5a ), Ruxolitinib effectively inhibited STAT3 phosphorylation, and in a dose-dependent manner, in stimulated cells. Having shown that the phosphorylation of STAT3 was inhibited by Ruxolitinib, we examined the 
DISCUSSION
Immune responses to pathogens involving the activation of pro-inflammatory cytokines are part of the defence against microbial invasion and enhance clearance of pathogens. Chlamydia is an obligate intracellular parasite with a unique biphasic life cycle. Excessive production of pro-inflammatory cytokines will harm chlamydial survival. Previous studies demonstrated that Chlamydia is able to regulate immune responses via modulated expression of certain immune system molecules, including cytokines [28, 29] . IL-10 is the main anti-inflammatory cytokine and plays a central role in the regulation of immune responses to pathogens [28] . Interestingly, previous studies revealed that Chlamydia induces the expression of IL-10 by monocytes, macrophages, dendritic cells and fibroblasts [30] [31] [32] [33] . Hence, it appears that this cytokine may be involved in the pathogenesis of Chlamydia infection. In addition, previous studies also demonstrated that IL-10 suppresses the expression of several pro-inflammatory molecules that are involved in immune responses against Chlamydia infections [34, 35] . Yilma et al. also revealed that exogenous IL-10 inhibited the secretion of IL-6, IL-8 and TNF-a by C. trachomatisinfected human epithelial cells and mouse macrophages [21] . Therefore, these results indicate that IL-10 up-regulation can be used by Chlamydia to modulate host cell immune responses. However, the molecular mechanisms of IL-10 production and suppression of host cell immune responses are not well understood.
It has been shown that signalling pathways involve the production of IL-10. For example, IL-10 was up-regulated in a p38-dependent fashion in macrophages infected with porcine reproductive and respiratory syndrome virus [36] . As an intracellular bacterial pathogen, Chlamydia modulated host cell signalling pathways [37] [38] [39] . In the present study, we demonstrated that IL-10 mRNA and protein levels were significantly up-regulated and were dose-dependent in C. trachomatis-stimulated human PBMCs. The production of IL-10 increased at 8 h post-stimulation, and peaked at 48 h. Our study also showed that C. trachomatis stimulation significantly stimulated ERK and p38 phosphorylation. Moreover, through the use of signal transduction pathway specific inhibitors, we further demonstrated that ERK and p38 pathways were involved in the up-regulation of IL-10 production in C. trachomatis-stimulated human PBMCs. These results suggested that the ERK and p38 pathways play important roles in the induction of IL-10 during C. trachomatis stimulation. Interestingly, Inhibition of either ERK or p38 activation led to a reduction, but not abrogation, of IL-10 expression, which suggests that these two pathways may cooperate in C. trachomatis-induced IL-10 production. In addition, previous studies also demonstrated that several pro-inflammatory cytokines are up-regulated in an ERKand p38-dependent fashion in C. trachomatis-infected cells [ 27, 40] . These results suggest that ERK and p38 signalling pathways may play importance roles in maintaining the balance between pro-and anti-inflammatory responses in stimulated cells.
Exogenous IL-10 inhibited pro-inflammatory cytokine production by C. trachomatis-infected human epithelial cells and mouse macrophages [21] . In order to investigate whether endogenous IL-10 has the same function as exogenous IL-10 in C. trachomatis-stimulated human PBMCs, an IL-10 antibody was utilized to treat human PBMCs. The results showed that neutralization of IL-10 using anti-IL-10 antibody resulted in a significant increase in protein and mRNA levels of IL-6, IL-8 and TNF-a. Therefore, it can be concluded that down-regulation of pro-inflammatory cytokines and inhibition of excessive immunity in human PBMCs induced by C. trachomatis is probably mediated through IL-10. Moreover, we further demonstrated that IL-10 immunosuppressive activity is mainly mediated by the JAK/STAT3 signalling pathway. First, the levels of phosphorylated STAT3 were enhanced in a time-and dosedependent manner in C. trachomatis-stimulated human PBMCs. Second, neutralization of IL-10 using anti-IL-10 antibody resulted in a significant decrease of phosphorylated STAT3, suggesting that STAT3 phosphorylation is dependent on the production of IL-10. Third, the level of phosphorylated STAT3 was significantly lower when PBMCs were treated with the chemical inhibitor Ruxolitinib. Finally, the production of IL-6, IL-8 and TNFa was significantly increased in C. trachomatis-stimulated human PBMCs treated with Ruxolitinib. Interestingly, Sun Y et al. reported that the levels of STAT3 mRNA and phosphorylated STAT3 protein were also significantly increased in C. psittaci-infected HeLa cells [41] . It was also reported that Chlamydia can up-regulate the levels of TLR2/TLR4 and MyD88 mRNA [42] , and it was shown to engage TLR2/ TLR4 signalling to increase STAT3 activation [43] . Previous studies demonstrated that TLR2-MYD88 can activate the MAPK survival pathway, including the ERK and p38 survival pathways [17] . These results suggest that Chlamydia may directly activate the TLR2-MYD88 cascade, leading to MAPK activation and IL-10 transcription,and then IL-10 activation of STAT3. Following STAT3 tyrosine phosphorylation, STAT3 homodimerized and translocated to the nucleus and interacted with STAT-binding element regions within the promoters of IL-10 target genes, which led to the up-regulation of target genes including the suppressor of cytokine signalling 3 (SOCS3) [44] . However, it is unclear whether IL-10 induced by C. trachomatis inhibits the production of pro-inflammatory cytokines by SOCS3 via the JAK/STAT3 signalling pathway, which needs further investigation.
IL-10 is a potent anti-inflammatory cytokine that plays a crucial role in preventing inflammatory and autoimmune pathologies. Previous studies demonstrated that the lack of anti-inflammatory action of IL-10 is associated with enhanced Chlamydia eradication, but led to severe inflammation in IL-10 knockout mice [45] . Moreover, previous studies also demonstrated that IL-10 deficiency led to increased antigen presentation by APCs and increased the clearance of Chlamydia [46] . Thus impaired IL-10 expression can enhance the clearance of C. trachomatis during an acute infection, but also exaggerate the inflammatory response, resulting in exacerbated immunopathology and tissue damage. Previous studies demonstrated that C. trachomatis induced the expression of IL-10 [16] , which indicates that C. trachomatis can harness the immunosuppressive capacity of IL-10 to limit host immune response and facilitate its own survival. However, the mechanisms involved in up-regulation of IL-10 and inhibition of pro-inflammatory cytokines in human PBMCs during Chlamydia infection are poorly understood. Our data demonstrate that C. trachomatis up-regulates IL-10 production in human PBMCs in an ERK-and p38-dependent fashion. Moreover, IL-10 inhibits the production of pro-inflammatory cytokines by activating the JAK/STAT signalling pathway. 
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